Baxter
BAX
#1028
Rank
$18.09 B
Marketcap
$35.51
Share price
1.20%
Change (1 day)
-27.46%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Revenue for Baxter (BAX)

Revenue in 2024 (TTM): $14.89 B

According to Baxter's latest financial reports the company's current revenue (TTM) is $14.89 B. In 2023 the company made a revenue of $14.81 B an increase over the years 2022 revenue that were of $14.79 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Baxter from 2001 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $14.89 B0.53%
2023 $14.81 B0.11%
2022 $14.79 B15.75%
2021 $12.78 B9.52%
2020 $11.67 B2.74%
2019 $11.36 B2.17%
2018 $11.12 B5.3%
2017 $10.56 B3.92%
2016 $10.16 B1.96%
2015 $9.96 B-34.35%
2014 $15.18 B-0.08%
2013 $15.19 B7.08%
2012 $14.19 B2.14%
2011 $13.89 B8.18%
2010 $12.84 B2.24%
2009 $12.56 B1.73%
2008 $12.34 B9.63%
2007 $11.26 B8.53%
2006 $10.37 B5.37%
2005 $9.84 B3.58%
2004 $9.50 B6.66%
2003 $8.91 B10.95%
2002 $8.03 B4.85%
2001 $7.66 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$220.57 B 1,381.14%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.96 B 40.77%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.70 B-1.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.71 B 32.39%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.86 B-94.21%๐Ÿ‡บ๐Ÿ‡ธ USA
$42.49 B 185.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.29 B-97.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.42 B-30.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$32.36 B 117.32%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$2.25 B-84.84%๐Ÿ‡บ๐Ÿ‡ธ USA